Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|117|2|109-114

ISSN： 0001-5792

Source： Acta Haematologica, Vol.117, Iss.2, 2006-11, pp. : 109-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Remission Induction by Granulocyte Colony-Stimulating Factor in Hypoplastic Acute Myelogenous Leukemia Complicated by Infection

By  

Acta Haematologica, Vol. 99, Iss. 4, 1998-05 ,pp. : 224-230

Karger

Access to resources Recommend Favorite

Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 192-197

Karger

Access to resources Recommend Favorite

Prophylactic Use of Granulocyte Colony-Stimulating Factor after Chemotherapy Does Not Affect Survival Rate in Acute Myeloid Leukemia: A Meta-Analysis

By  

Acta Haematologica, Vol. 121, Iss. 4, 2009-06 ,pp. : 223-226

Karger

Access to resources Recommend Favorite

Pilot Study of Gemtuzumab Ozogamicin (GO), Fludarabine, Cytarabine and Idarubicin Combined Regimen (GO-FLAI) as First-Line Induction Therapy plus GO Alone as Consolidation Therapy for Elderly Acute Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-03 ,pp. : 7-9

Karger

Access to resources Recommend Favorite

Remission Induction of Refractory Anaemia with Excess Blasts in Transformation by Sole Treatment with Granulocyte Colony-Stimulating Factor with Persistent Chromosomal Abnormality

By  

Acta Haematologica, Vol. 107, Iss. 3, 2002-04 ,pp. : 177-181

Karger

Access to resources Recommend Favorite